Constrictive pericarditis associated with sarcoidosis

Garrett, J. R.; O'Neill, Hilary; Blake, Sean

doi:10.1016/0002-8703(84)90394-6

Cited by 52 publications

(17 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is observed in fewer than 10% of patients with cardiac sarcoidosis, and these patients usually remain asymptomatic. Small pericardial effusions detected by echocardiography were found in 19% of patients with sarcoidosis [23, 24]. Direct valvular involvement occurs in fewer than 3% of patients, but valvular incompetence secondary to papillary muscle dysfunction can be seen in approximately 68% of patients [25].…”

Section: Pericardial Effusion/valvular Involvement/ventricular Aneurysmmentioning

confidence: 99%

Cardiac sarcoidosis: a comprehensive review

Sekhri

Sanal²,

DeLorenzo³

et al. 2011

aoms

249

234

View full text Add to dashboard Cite

Sarcoidosis is a multisystem granulomatous disease of unknown etiology characterized by noncaseating granulomas in involved organs. Organs involved with sarcoidosis include lymph nodes, skin, lung, central nervous system, and eye. Only 40-50% of patients with cardiac sarcoidosis diagnosed at autopsy have the diagnosis made during their lifetime. Cardiac sarcoidosis can manifest itself as complete heart block, ventricular arrhythmias, congestive heart failure, pericardial effusion, pulmonary hypertension, and ventricular aneurysms. Diagnostic tests such as the electrocardiogram, two-dimensional echocardiography, cardiac magnetic resonance imaging, positron emission tomography scan, radionuclide scan, and endomyocardial biopsy can be helpful in the early detection of cardiac sarcoidosis. Considering the increased risk of sudden death, cardiac sarcoidosis is an indication for early treatment with corticosteroids or other immunosuppressive agents. Other treatments include placement of a pacemaker or implantable defibrillator to prevent sudden death. In refractory cases, cardiac transplantation should be considered.

show abstract

Section: Pericardial Effusion/valvular Involvement/ventricular Aneurysmmentioning

confidence: 99%

Cardiac sarcoidosis: a comprehensive review

Sekhri

Sanal²,

DeLorenzo³

et al. 2011

aoms

249

234

View full text Add to dashboard Cite

show abstract

“…Pericarditis is a rare clinical presentation (1,7,12). Direct granulomatous involvement of cardiac valves (less than 3%), coronary artery granulomatous disease leading to myocardial ischemia, constrictive pericarditis, and intracardiac masses are other rare clinical presentations of CS (1,7,(42)(43)(44). Although direct valvular involvement is rare, valvular insufficiency secondary to papillary muscle dysfunction is seen in 68% of patients with CS (42).…”

Section: Clinical Manifestationsmentioning

confidence: 99%

Sarcoidosis and the heart: A review of the literature

İpek

Demirelli

Ermis

et al. 2015

IRDR

View full text Add to dashboard Cite

“…Both cardiac tamponade and constrictive pericarditis due to sarcoidosis are rare and have been described in case reports [26]. N, number of patients; AV, atrioventricular; BBB, bundle branch block; SVT, supraventricular tachycardia; V-Tach, ventricular tachycardia; CHF, congestive heart failure; SD, sudden death.…”

Section: Pericarditismentioning

confidence: 99%